the National Assembly in favor of together with minimal shares within the legislation | EUROtoday

Get real time updates directly on you device, subscribe now.

Faced with drug shortages, MEPs are placing strain on the pharmaceutical trade. On Thursday February 29, the National Assembly unanimously adopted a socialist invoice geared toward “strengthen obligations” make producers construct up shares. The textual content paves the best way for the inclusion of minimal shares within the legislation and supplies for elevated sanctions within the occasion of non-compliance with these obligations.

“Not being able to access the medications we need is an indescribable anguish (…) for parents, for patients »defended the socialist deputy Valérie Rabault, author of the text, which will now have to go to the Senate.

“The number of drugs in shortage has increased tenfold in ten years”insisted the MP, saying she had “awareness that the heart of the subject remains production”and calling for “a medium and long term industrial strategy”.

Read the decryption | Article reserved for our subscribers Drug shortages: a unending disaster

The model of its textual content adopted on Thursday, amended particularly by the overall rapporteur of the Social Security funds, Stéphanie Rist (Renaissance), plans to incorporate within the legislation minimal shares that are at present solely supplied for in a decree. They could be between a minimal week and a most of 4 months for medicines on the whole.

Another vary is retained for “drugs of major therapeutic interest” (MITM), particularly these for which an interruption of therapy is prone to jeopardize the very important prognosis of sufferers within the brief or medium time period, or represents a big lack of alternative for sufferers. In this case, the stock flooring and ceilings would enhance to a minimal of two months and a most of 4 months.

Heightened sanctions

In sure instances set by decree, the director of the medicines company (ANSM) may impose smaller shares. But it might even have the chance, after the adoption of an modification by Mme Rabault, to impose shares of as much as six months for MITMs for which a inventory scarcity or a danger of scarcity is highlighted or declared.

“Increasing stocks of medicines or even making them compulsory are not the alpha and omega of managing shortages”warned the Minister of Health, Frédéric Valletoux, stressing that past the necessity to relocate a part of the manufacturing in Europe, it was essential to act on the unequal distribution of shares on French territory and on “the visibility of these stocks”.

Read additionally | Article reserved for our subscribers Drug shortages: the roadmap promised by the federal government is lengthy overdue

The invoice additionally plans to confer on the ANSM powers of on-site inspection, but in addition to extend the penalties supplied for by legislation, which may go as much as 50% of the turnover of the final monetary 12 months. regarding the drugs in query, with a ceiling raised to five million euros (in comparison with 30% and 1 million euros at present).

The World with AFP

Reuse this content material